Soligenix Investor Relations Material
Latest events
Q1 2025
8 May, 2025
Q4 2024
21 Mar, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Soligenix Inc
Access all reports
Soligenix Inc is a U.S.-based biopharmaceutical company focused on developing and commercializing treatments for rare diseases and biodefense indications. The company works on therapies for inflammatory conditions, oncology, and infectious diseases, with both proprietary drug candidates and government-supported programs. The company is headquartered in Princeton, New Jersey, and its shares are listed on the NASDAQ.
Latest articles
)
Global Doughmination: Breaking Down Domino's Pizza
Inside the rise of Domino's Pizza: how franchising, delivery control, and supply chain mastery built one of the world's most efficient food empires.
18 Jul 2025
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
Ticker symbol
SNGX
Country
🇺🇸 United States